Stock A092730 NEOPHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions NeoPharm CO., LTD.

Equities

A092730

KR7092730001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
28,400 KRW +3.27% Intraday chart for NeoPharm CO., LTD. +5.38% +9.86%
2023 NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2019 NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. A092730 Stock
  4. Revisions NeoPharm CO., LTD.